Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Concurrent Circulating Tumor DNA and Tissue Genotyping-Ready for Prime Time?

JAMA network open - 2 Jan 2024

Bleiberg Benjamin A, Aggarwal Charu

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circulating Tumor DNA
Share to Genotype

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38252442
DOI: 10.1001/jamanetworkopen.2023.51679
PMCID: PMC13003226

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Concurrent Circulating Tumor DNA and Tissue Genotyping-Ready for Prime Time?PMID 38252442Read ↗

Reliability of liquid biopsy analysis: an inter-laboratory comparison of circulating tumor DNA extraction and sequencing with different platformsSemantic proximity Read ↗

Technical progress in circulating tumor DNA analysis using next generation sequencingSemantic proximity Read ↗

Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer DetectionSemantic proximity Read ↗

Harnessing cell-free DNA: plasma circulating tumour DNA for liquid biopsy in genitourinary cancersSemantic proximity Read ↗

Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?Semantic proximity Read ↗

Cell-free circulating tumor DNA profiling in cancer managementSemantic proximity Read ↗

Circulating cell-free DNA for non-invasive cancer managementSemantic proximity Read ↗

Circulating tumor cells versus tumor-derived cell-free DNA: rivals or partners in cancer care in the era of single-cell analysis?Semantic proximity Read ↗

Advances in genomic characterization of circulating tumor cellsSemantic proximity Read ↗

Circulating Tumor DNA Testing—Liquid Biopsy of a CancerSemantic proximity Read ↗

Circulating Tumor DNA as a Cancer Biomarker: Fact or Fiction?Semantic proximity Read ↗

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverageSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.